Qube Research & Technologies (QRT)
TCRT icon

Qube Research & Technologies (QRT)’s Alaunos Therapeutics TCRT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11
Closed -$73 – 4093
2024
Q2 		$73 Hold
11
– – ﹤0.01% 3461
2024
Q1 		$190 Hold
11
– – ﹤0.01% 4142
2023
Q4 		$112 Sell
11
-1
-8% -$12 ﹤0.01% 4021
2023
Q3 		$233 Buy
+12
New +$517 ﹤0.01% 3720
2023
Q1 		– Sell
-355
Closed -$34.6K – 3013
2022
Q4 		$34.6K Sell
355
-654
-65% -$94.8K ﹤0.01% 2182
2022
Q3 		$260K Buy
1,009
+49
+5% +$14.2K ﹤0.01% 1680
2022
Q2 		$179K Buy
+960
New +$91.7K ﹤0.01% 1753
2022
Q1 		– Sell
-2,532
Closed -$414K – 2994
2021
Q4 		$414K Buy
+2,532
New +$556K ﹤0.01% 1647
2021
Q3 		– Sell
-321
Closed -$127K – 2759
2021
Q2 		$127K Buy
+321
New +$150K ﹤0.01% 1898
2021
Q1 		– Sell
-261
Closed -$99K – 2405
2020
Q4 		$99K Buy
+261
New +$104K ﹤0.01% 1649
2020
Q2 		– Sell
-197
Closed -$72K – 1981
2020
Q1 		$72K Buy
+197
New +$102K ﹤0.01% 996

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
SWM
Sugarloaf Wealth Management Duluth, Georgia $529M AUM 14.14% 1-Year Est. Return

Qube Research & Technologies (QRT)'s TCRT Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Alaunos Therapeutics (TCRT) in Q3 2024, closing a stake of 11 shares — an estimated $73 sold.

Qube Research & Technologies (QRT) first reported a position in TCRT in Q1 2020 and held it in 11 quarters. The position peaked at $414K in Q4 2021. 29 funds tracked by Wall St. Rank hold TCRT as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining Alaunos Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 11 Alaunos Therapeutics shares in Q3 2024, an estimated $73.
  • Qube Research & Technologies (QRT) first reported a position in Alaunos Therapeutics in Q1 2020 and held it in 11 quarters.
  • Qube Research & Technologies (QRT)'s Alaunos Therapeutics position peaked at $414K in Q4 2021.
  • 29 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.